Sitemap

Vol.15 - No.3 (July 2024)

Report of the Committee

A large-scale, observational study to investigate the current status of diabetes complication and their prevention in Japan: incidence/risk factors for malignancies during follow-up—JDCP study 11 (English version)

Kenji Yamashiro, Hiroshi Takahashi, Yasuaki Hayashino, Hideki Origasa, Kazuo Izumi, Naoko Tajima & Rimei Nishimura 315–326

Consensus Report

A consensus statement from the Japan Diabetes Society (JDS): a proposed algorithm for pharmacotherapy in people with type 2 diabetes—2nd Edition (English version)

Ryotaro Bouchi, Tatsuya Kondo, Yasuharu Ohta, Atsushi Goto, Daisuke Tanaka, Hiroaki Satoh, Daisuke Yabe, Rimei Nishimura, Norio Harada, Hideki Kamiya, Ryo Suzuki, Toshimasa Yamauchi & JDS Committee on Consensus Statement Development 327–345

Introduction to Mini-Reviews

Advances in glucagon research ~ 100th anniversary: invitation to the new ‘glucagon-ology’

Dan Kawamori 346–347

Mini-Review

Advances in basic research on glucagon and alpha cells

Yoshitaka Hayashi 348–352

Mini-Review

Advances in clinical research on glucagon

Ichiro Horie & Norio Abiru 353–361

Mini-Review

Advances in the clinical measurement of glucagon: from diagnosis to therapy

Tadahiro Kitamura & Masaki Kobayashi 362–369

Review Article

Innovations and applications of ketone body monitoring in diabetes care

Naoki Sakane 370–378

Original Article

Changes in serum levels of liver-related parameters, uric acid, and hemoglobin in patients with type 2 diabetes mellitus under treatment with tofogliflozin—a post-hoc analysis of the UTOPIA study

Naoto Katakami, Tomoya Mita, Yasunori Sato, Hirotaka Watada & Iichiro Shimomura 379–388

Original Article

Exosomal UMOD gene expression and urinary uromodulin level as early noninvasive diagnostic biomarkers for diabetic nephropathy in type 2 diabetic patients

Shaimaa I. Barr, Sahar S. Bessa, Tarek M. Mohamed & Eman M. Abd El-Azeem 389–399

Original Article

Predictors of the effectiveness of isCGM usage in adults with type 1 diabetes mellitus: post-hoc analysis of the ISCHIA study

The ISCHIA Study Group, Takashi Murata, Yushi Hirota, Kiminori Hosoda, Ken Kato, Kunichi Kouyama, Ryuji Kouyama, Akio Kuroda, Yuka Matoba, Munehide Matsuhisa, Shu Meguro, Junnosuke Miura, Kunihiro Nishimura, Naoki Sakane, Akira Shimada, Shota Suzuki, Atsuhito Tone & Masao Toyoda 400–405

Original Article

Incidence of overt diabetes in pregnancy among women with 50-g glucose challenge test ≥ 200 mg/dL

Dittakarn Boriboonhirunsarn, Amporn Robkhonburi & Dawrueng Gusonkhum 406–413

Original Article

Impact of inpatient management of hyperglycemia on peripheral T cell markers in patients with type 2 diabetes

Tomohisa Kunii, Isao Usui, Teruo Jojima, Masanori Shimizu, Masato Kase, Shintaro Sakurai, Takuya Tomaru, Toshie Iijima & Yoshimasa Aso 414–420

Original Article

Association between erectile dysfunction and subjective well-being in primary care patients with type 2 diabetes

Hazem A. Sayed Ahmed, Ehaab Mahmoud Abdallah, Mohamed Abd Elwahed Mohamed, Tamis Mohamed Aboelfotoh, Hebatallah Nour-Eldein & Ahmed Mahmoud Fouad 421–432

Original Article

Impact of early-morning administration of rapid-acting insulin on the increase in blood glucose levels related to the dawn phenomenon in individuals with type 1 diabetes

Tomofumi Takayoshi, Yushi Hirota, Akane Yamamoto, Kai Yoshimura, Seiji Nishikage, Mariko Ueda & Wataru Ogawa 433–438

Original Article

The relationship between DASC-8 categories and the effectiveness of education on insulin self-injection techniques in elderly patients with diabetes

Taisuke Uchida, Hiroaki Ueno, Akari Sekishima, Hirotaka Sekishima, Ayaka Konagata, Takayuki Nakamura, Fumiko Kogo, Hiroki Nabekura, Yuri Tanaka, Koichiro Shimizu, Hideki Yamaguchi & Kazuya Shimoda 439–446

Original Article

A sensor-augmented pump with a predictive low-glucose suspend system could lead to an optimal time in target range during pregnancy in Japanese women with type 1 diabetes

Rie Kaneshima Tamura, Noriko Kodani, Arata Itoh, Shu Meguro, Hiroshi Kajio & Hiroshi Itoh 447–455

Original Article

Impact of health practice index and cardiovascular health metrics on incident cardiovascular disease according to glucose tolerance status

Koshiro Murai, Kazuya Fujihara, Mayuko Harada Yamada, Yasuhiro Matsubayashi, Takaho Yamada, Midori Iwanaga, Masaru Kitazawa, Masahiko Yamamoto, Taeko Osawa, Yuta Yaguchi, Satoru Kodama & Hirohito Sone 456–464

Original Article

Frequency and determinants of lipid management target achievement in primary prevention of cardiovascular disease in type 2 diabetes

Aika Miya, Akinobu Nakamura, Yuka Suzuki, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho & Tatsuya Atsumi 465–473

Original Article

Effects of dulaglutide and trelagliptin on beta-cell function in patients with type 2 diabetes: a randomized controlled study: DUET-beta study

Yoshinobu Kondo, Shinobu Satoh & Yasuo Terauchi 474–482

Original Article

Comparison of medication persistence and adherence in type 2 diabetes using a once-weekly regimen of DPP-4 inhibitor compared with once-daily and twice-daily regimens: a retrospective cohort study of Japanese health insurance claims data

Tetsuya Miwa, Shiori Yoshida, Akihiro Nakajima, Ruriko Koto & Rimei Nishimura 483–494

Original Article

Identification of herbal drug extracts that promote growth of Akkermansia muciniphila in high-fat diet fed mice

Shiho Fujisaka, Yoshiyuki Watanabe, Kazufumi Toume, Yoshitomo Morinaga, Allah Nawaz, Tomonobu Kado, Ayumi Nishimura, Muhammad Bilal, Muhammad Rahil Aslam, Yoshiko Igarashi, Yoshimi Nakagawa & Kazuyuki Tobe 495–506

Original Article

Influence of the COVID-19 pandemic on the achievement of guideline targets for HbA1c, blood pressure, and LDL cholesterol in people with diabetes in Japan

Shingo Kuwajima, Takahito Itoh, Tatsuya Sato, Shoya Ino, Satoru Shibata, Kouhei Ohno, Hiroyuki Hotta, Tomoaki Matsumoto, Hitoshi Ooiwa, Hirofumi Kubo & Takayuki Miki 507–517

Original Article

Uric acid is associated with type 2 diabetes: data mining approaches

Amin Mansoori, Davoud Tanbakuchi, Zahra Fallahi, Fatemeh Asgharian Rezae, Reihaneh Vahabzadeh, Sara Saffar Soflaei, Reza Sahebi, Fatemeh Hashemzadeh, Susan Nikravesh, Fatemeh Rajabalizadeh, Gordon Ferns, Habibollah Esmaily & Majid Ghayour-Mobarhan 518 - 527

Original Article

Patients with diabetes and obesity exhibit characteristics in eating and coping behaviors and personality traits

Masahiro Saito, Isao Usui, Norio Sugawara, Teruo Jojima, Shintaro Sakurai, Haruka Kishi, Masaaki Sagara, Takuya Tomaru, Toshie Iijima, Kazutaka Shimoda, Norio Yasui-Furukori & Yoshimasa Aso 528–534

Original Article

Impact of treatment cessation on incidence and progression of retinopathy in Japanese patients with type 2 diabetes mellitus: a retrospective cohort study

Yukiko Shinzato, Yoshiro Nakayama, Shiki Okamoto, Jasmine F. Millman, Tsugumi Uema, Ken-ichiro Honma, Atsuko Tamaki, Moriyuki Uehara, Taiki Teruya, Takamitsu Yabiku, Yohei Ishiki, Ken Yonaha, Ko-ichiro Arakaki, Moritake Higa, Hideki Koizumi, Koshi Nakamura, Michio Shimabukuro & Hiroaki Masuzaki 535–543

Original Article

Analysis of factors affecting the accuracy of low-dose insulin dosage using syringes and vials: a cross-sectional study in a Japanese regional hospital

Manabu Kondo, Rika Saji, Yuka Yamada, Mari Hayashi & Tomoko Shirai 544–549

Original Article

Naming hypoglycemia: a narrative tool for young people with type 1 diabetes and their families

Francisco Sobral do Rosário, Marta Soares, Filipe Mesquita & João Filipe Raposo 550–561

Original Article

Severe periodontal disease in Japanese patients with high HbA1c levels: a cross-sectional study

Noboru Kurinami, Kenji Ashida, Seigo Sugiyama, Yoko Morito, Akira Yoshida, Kunio Hieshima, Fumio Miyamoto, Keizo Kajiwara, Katsunori Jinnouchi, Hideaki Jinnouchi & Masatoshi Nomura 562–568

Original Article

Efficacy and safety of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide in Japanese patients with type 2 diabetes mellitus

Chihiro Yoneda, Junji Kobayashi & Nobuichi Kuribayashi 569–576

Case Report

Type 1 diabetes mellitus following COVID-19 vaccination: a report of two cases and review of literature

Shota Mochizuki, Junnosuke Miura, Kiwako Ucida, Ryo Kubota, Hirona Fujikawa, Satoshi Takagi, Naoshi Yoshida, Sachiko Ootake, Chika Fujimori, Akihito Shinohara, Junji Tanaka & Tetsuya Babazono 577–582

Case Report

A case of rapidly progressive insulin-dependent diabetes mellitus without islet autoantibodies developed over two years after the first dose of nivolumab

Kota Nishihama, Yuko Okano, Chisa Inoue, Kanako Maki, Kazuhito Eguchi, Soichiro Tanaka, Atsuro Takeshita, Mei Uemura, Taro Yasuma, Toshinari Suzuki, Esteban C. Gabazza & Yutaka Yano 583–588

Case Report

Pregnancy-associated fulminant type 1 diabetes: a case report and review of the literature

Hikari Nebashi, Hitoshi Matsui, Chika Tei, Masanori Hasebe & Hiroko Takanashi 589–593

Case Report

A case of diabetic ketoacidosis with prurigo pigmentosa as a dermadrome

Sachiko Hiraoka & Muneo Kawasumi 594–599

Case Report

A case of congenital hyperinsulinism presenting with diabetes after long-term diazoxide therapy

Miwa Furuzono, Mika Makimura & Kenichi Miyako 600–604

Case Report

Immune checkpoint inhibitor-related type 1 diabetes mellitus which develops long after treatment discontinuation: a case report and review of literature

Yoshinari Obata, Miho Takemoto, Taka-aki Sakaue, Satoshi Kawata, Kosuke Mukai, Kazuyuki Miyashita, Junji Kozawa, Hitoshi Nishizawa & Iichiro Shimomura 605–610

Case Report

A case of insulinoma misidentified as schizophrenia due to its manifestation in neuropsychiatric symptoms

Tomoyuki Haba, Kengo Yamakawa, Sayako Ozeki, Akira Sumida, Takehiro Kato, Eiji Kuroda, Takako Maruyama, Takaaki Murakami & Daisuke Yabe 611–615

Case Report

Pseudo-nephropathy and hyper-excretion of urinary C-peptide: an overlooked adverse effect of an angiotensin receptor–neprilysin inhibitor (ARNI)

Yoshito Itoh, Shigehito Suzuki, Ryohei Mineo, Sho Sasaki, Sachiko Tamba, Takuya Sugiyama & Koji Yamamoto 616–620

Case Report

Case of new-onset fulminant type 1 diabetes mellitus accompanied by autoimmune thyroid disease after SARS-CoV-2 infection

Keisuke Murakawa, Hiroaki Aasi, Kanako Sato, Saori Yoshioka, Hiroyuki Sho, Ryoko Inui, Motohiro Kosugi, Yoji Hazama & Tetsuyuki Yasuda 621–626

Short Communication

Current status of screening and management of gestational diabetes in early pregnancy: a questionnaire survey in Japan

Maki Yokoyama, Kei Miyakoshi, Sayuri Nakanishi, Noriyuki Iwama, Shigeru Aoki, Ichiro Yasuhi & Takashi Sugiyama 627–631

Short Communication

Glycemic control of once-weekly and other administration frequencies for DPP-4 inhibitor in patients with type 2 diabetes: a real-world retrospective cohort study

Ruriko Koto, Shiori Yoshida, Akihiro Nakajima, Tetsuya Miwa & Rimei Nishimura 632–637

Correction

Correction: New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version)

Akira Shimada, Eiji Kawasaki, Norio Abiru, Takuya Awata, Yoichi Oikawa, Haruhiko Osawa, Hiroshi Kajio, Junji Kozawa, Kazuma Takahashi, Daisuke Chujo, Shinsuke Noso, Tomoyasu Fukui, Junnosuke Miura, Kazuki Yasuda, Hisafumi Yasuda, Akihisa Imagawa & Hiroshi Ikegami 638–639

Update: August 2, 2024